Mitochondria: A promising target for anticancer alkaloids

Current Topics in Medicinal Chemistry

Volumn 13, Issue 17, 2013, Pages 2171-2183

  Urra, Félix A ^a   Córdova Delgado, Miguel ^a   Pessoa Mahana, Hernán ^a   Ramírez Rodríguez, Oney ^a   Weiss López, Boris ^a   Ferreira, Jorge ^a   Araya Maturana, Ramiro ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Alkaloids; Apoptosis; Cancer cells; Delivery; Endoplasmic reticulum; Mitochondria; Targeting

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ALKALOID DERIVATIVE; ASCIDIDEMIN; BERBERINE; CAPSAICIN; CHELERYTHRINE; CHLOROQUINE; COLCHICINE; ELLIPTICINE; EM 011; EVODIAMINE; HARMINE; JCTH 4; LAMELLARIN; LYCOPODINE; LYCORINE; MATRINE; MJ 29; NAAMIDINE; NAVELBINE; NOCODAZOLE; NOSCAPINE; PACLITAXEL; PANCRATISTATIN; SANGUINARINE; SK 228; STREPTOCHLORIN; SWAINSONINE; TETRANDRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BEHCET DISEASE; BIOENERGY; BIOGENESIS; CANCER CELL; CELL DEATH; CELL STRUCTURE; CYTOTOXICITY; DEPOLARIZATION; ENDOPLASMIC RETICULUM; FAMILIAL MEDITERRANEAN FEVER; GOUT; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; METABOLIC INHIBITION; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; NEOPLASM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PERICARDITIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; MITOCHONDRIA; MOLECULAR STRUCTURE; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84887944204     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113139990150     Document Type: Article

References (142)

1. Olano, C.; Méndez, C.; Salas, J., Antitumor compounds from marine Actinomycetes. Mar. Drugs, 2009, 7, 210-248.
2. Wink, M., Molecular Modes of Action of Cytotoxic Alkaloids: From DNA Intercalation, Spindle Poisoning, Topoisomerase Inhibition to Apoptosis and Multiple Drug Resistance. In: The Alkaloids, Cordell, G., Ed. Elsevier, 2007, 64, 1-47.
3. Mitchell, W., Natural products from synthetic biology. Curr. Opin. Chem. Biol, 2011, 15(4), 505-515.
4. Dumontet, C.; Jordan, M. A., Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov, 2010, 9(10), 790-803.
5. Rovini, A.; Savry, A.; Braguer, D.; Carré, M., Microtubule-targeted agents: When mitochondria become essential to chemotherapy. Biochim. Biophys. Acta, 2011, 1807(6), 679-688.
6. Kaminskyy, V.; Kulachkovskyy, O.; Stoika, R., A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. Toxicol. Lett, 2008, 177(3), 168-181.
7. Kavallaris, M., Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer, 2010, 10(3), 194-204.
8. Vandenabeele, P.; Galluzzi, L.; Vanden Berghe, T.; Kroemer, G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol, 2010, 11(10), 700-714.
9. Lee, J.; Giordano, S.; Zhang, J., Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J, 2012, 441(2), 523-540.
10. Reichert, A. S.; Neupert, W., Mitochondriomics or what makes us breathe. Trends Genet, 2004, 20(11), 555-562.
11. Chernyak, B.; Pletjushkina, O.; Izyumov, D.; Lyamzaev, K.; Avetisyan, A., Bioenergetics and death. Biochemistry (Mosc), 2005, 70, 240-245.
12. de Moura, M. B.; dos Santos, L. S.; Van Houten, B., Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen, 2010, 51(5), 391-405.
13. Ralph, S. J.; Rodríguez-Enríquez, S.; Neuzil, J.; Moreno-Sánchez, R., Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol. Aspects Med, 2010, 31(1), 29-59.
14. Smith, R. A. J.; Hartley, R. C.; Cochemé, H. M.; Murphy, M. P., Mitochondrial pharmacology. Trends Pharmacol. Sci,. 2012, 33(6), 341-352.
15. Wallace, D.; Fan, W.; Procaccio, V., Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. Mech. Dis, 2010, 5, 297-348.
16. Galluzzi, L.; Morselli, E.; Kepp, O.; Vitale, I.; Rigoni, A.; Vacchelli, E.; Michaud, M.; Zischka, H.; Castedo, M.; Kroemer, G., Mitochondrial gateways to cancer. Mol. Aspects Med, 2010, 31(1), 1-20.
17. Tennant, D. A.; Duran, R. V.; Gottlieb, E., Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer, 2010, 10(4), 267-277.
18. Chan, D., Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol, 2006, 22, 79-99.
19. Yousif, L. F.; Stewart, K. M.; Horton, K. L.; Kelley, S. O., Mitochondria-penetrating peptides: Sequence effects and model cargo transport. ChemBioChem, 2009, 10(12), 2081-2088.
20. Chen, G.; Wang, F.; Trachootham, D.; Huang, P., Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion, 2010, 10(6), 614-625.
21. D'Souza, G. G. M.; Weissig, V., Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet. Expert. Opin. Drug Deliv, 2009, 6(11), 1135-1148.
22. Frantz, M.-C.; Wipf, P., Mitochondria as a target in treatment. Environ. Mol. Mutagen, 2010, 51(5), 462-475.
23. Fulda, S.; Galluzzi, L.; Kroemer, G., Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov, 2010, 9(6), 447-464.
24. Heller, A.; Brockhoff, G.; Goepferich, A., Targeting drugs to mitochondria. Eur. J. Pharm. Biopharm, 2012, 82(1), 1-18.
25. Pathania, D.; Millard, M.; Neamati, N., Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev, 2009, 61(14), 1250-1275.
26. Smith, R.; Murphy, M., Mitochondria-targeted antioxidants as therapies. Discov. Med, 2011, 11, 106-114.
27. Weissig, V., From Serendipity to Mitochondria-Targeted Nanocarriers. Pharm. Res, 2011, 28, 2657-2668.
28. Westermann, B., Bioenergetic role of mitochondrial fusion and fission. Biochim. Biophys. Acta, 2012, 1817(10), 1833-1838.
29. D'Souza, G. G. M.; Wagle, M. A.; Saxena, V.; Shah, A., Approaches for targeting mitochondria in cancer therapy. Biochim. Biophy. Acta, 2011, 1807(6), 689-696.
30. Brand, M. D.; Nicholls, D. G., Assessing mitochondrial dysfunction in cells. Biochem. J, 2011, 435(2), 297-312.
31. Solaini, G.; Sgarbi, G.; Baracca, A., Oxidative phosphorylation in cancer cells. Biochim. Biophys., Acta. 2011, 1807(6), 534-542.
32. Lemarie, A.; Grimm, S., Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene, 2011, 30(38), 3985-4003.
33. Pedersen, P., Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect, " i. e., elevated glycolysis in the presence of oxygen. J. Bioenerg. Biomembr, 2007, 39(3), 211-222.
34. Ralph, S. J.; Rodríguez-Enríquez, S.; Neuzil, J.; Saavedra, E.; Moreno-Sánchez, R., The causes of cancer revisited: "Mitochondrial malignancy" and ROS-induced oncogenic transformation-Why mitochondria are targets for cancer therapy. Mol. Aspects Med, 2010, 31(2), 145-170.
35. Rohlena, J.; Dong, L.; Ralph, S.; Neuzil, J., Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid. Redox Signal, 2011, 15(12), 2951-74.
36. Kemény-Beke, Á.; Aradi, J.; Damjanovich, J.; Beck, Z.; Facskó, A.; Berta, A.; Bodnár, A., Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett, 2006, 237(1), 67-75.
37. Kaminskyy, V.; Lin, K.; Filyak, Y.; Stoika, R., Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells, Cell Biol. Int, 2008, 32, 271-7.
38. Serafim, T. L.; Matos, J. A. C.; Sardao, V. A.; Pereira, G. C.; Branco, A. F.; Pereira, S. L.; Parke, D.; Perkins, E. L.; Moreno, A. J. M.; Holy, J.; Oliveira, P. J., Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells-Nuclear vs. mitochondrial effects. Biochem. Pharmacol, 2008, 76(11), 1459-1475.
39. Choi, W. Y.; Kim, G. Y.; Lee, W. H.; Choi, Y. H., Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen speciesmediated mitochondrial pathway. Chemotherapy, 2008, 54(4), 279-287.
40. Hussain, A. R.; Al-Jomah, N. A.; Siraj, A. K.; Manogaran, P.; Al-Hussein, K.; Abubaker, J.; Platanias, L. C.; Al-Kuraya, K. S.; Uddin, S., Sanguinarine-dependent Induction of apoptosis in primary effusion lymphoma cells. Cancer Res, 2007, 67(8), 3888-3897.
41. Ip, S. W.; Lan, S. H.; Lu, H. F.; Huang, A. C.; Yang, J. S.; Lin, J. P.; Huang, H. Y.; Lien, J. C.; Ho, C. C.; Chiu, C. F.; Wood, W. G.; Chung, J. G., Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress. Hum. Exp. Toxicol, 2012, 31(6), 539-549.
42. Yang, K.; Pyo, J.; Kim, G.-Y.; Yu, R.; Han, I.; Ju, S.; Kim, W.; Kim, B.-S., Capsaicin induces apoptosis by generating reactive oxygen species and disrupting mitochondrial transmembrane potential in human colon cancer cell lines. Cell Mol. Biol. Lett, 2009, 14(3), 497-510.
43. Zhang, R.; Humphreys, I.; Sahu, R.; Shi, Y.; Srivastava, S., In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis, 2008, 13(12), 1465-1478.
44. Lu, H.-F.; Chen, Y.-L.; Yang, J.-S.; Yang, Y.-Y.; Liu, J.-Y.; Hsu, S.-C.; Lai, K.-C.; Chung, J.-G., Antitumor activity of capsaicin on human colon cancer cells in vitro and Colo 205 tumor xenografts in vivo. J. Agric. Food Chem, 2010, 58(24), 12999-13005.
45. Pramanik, K. C.; Boreddy, S. R.; Srivastava, S. K., Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PLoS ONE, 2011, 6(5), e20151.
46. Tillhon, M.; Guamán Ortiz, L. M.; Lombardi, P.; Scovassi, A. I., Berberine: New perspectives for old remedies. Biochem. Pharmacol, 2012, 84(10), 1260-1267.
47. Vuddanda, P. R.; Chakraborty, S.; Singh, S., Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert. Opin. Investig. Drugs, 2010, 19(10), 1297-1307.
48. Pereira, G. C.; Branco, A. F.; Matos, J. A. C.; Pereira, S. L.; Parke, D.; Perkins, E. L.; Serafim, T. L.; Sardao, V. A.; Santos, M. S.; Moreno, A. J. M.; Holy, J.; Oliveira, P. J., Mitochondrially targeted effects of berberine [natural yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo(g)-1, 3-benzodioxolo(5, 6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J. Pharmacol. Exp. Ther, 2007, 323(2), 636-649.
49. Diogo, C.; Machado, N.; Barbosa, I.; Serafim, T.; Burgeiro, A.; Oliveira, P., Berberine as a promising safe anti-cancer agent-is there a role for mitochondria? Curr. Drug Targets, 2011, 12(6), 850-9.
50. Pereira, C. V.; Machado, N. G.; Oliveira, P. J., Mechanisms of Berberine (Natural Yellow 18)-induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator. Toxicol. Sci, 2008, 105 (2), 408-417.
51. Chevrollier, A.; Loiseau, D.; Reynier, P.; Stepien, G., Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. Biochim. Biophys. Acta, 2011, 1807(6), 562-567.
52. Sharaf el dein, O.; Mayola, E.; Chopineau, J.; Brenner, C., The adenine nucleotide translocase 2, a mitochondrial target for anticancer biotherapy. Curr. Drug Targets, 2011, 12(6), 894-901.
53. Kluza, J.; Gallego, M.-A.; Loyens, A.; Beauvillain, J.-C.; Sousa-Faro, J.-M. F.; Cuevas, C.; Marchetti, P.; Bailly, C., Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug Lamellarin D. Cancer Research, 2006, 66(6), 3177-3187.
54. Ballot, C.; Kluza, J.; Martoriati, A.; Nyman, U.; Formstecher, P.; Joseph, B.; Bailly, C.; Marchetti, P., Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D. Mol. Cancer Ther, 2009, 8(12), 3307-17.
55. Ballot, C.; Kluza, J.; Lancel, S.; Martoriati, A.; Hassoun, S.; Mortier, L.; Vienne, J.-C.; Briand, G.; Formstecher, P.; Bailly, C.; Nevière, R.; Marchetti, P., Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D. Apoptosis, 2010, 15(7), 769-781.
56. Verfaillie, T.; Rubio, N.; Garg, A. D.; Bultynck, G.; Rizzuto, R.; Decuypere, J. P.; Piette, J.; Linehan, C.; Gupta, S.; Samali, A.; Agostinis, P., PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell. Death. Differ, 2012, 19(11), 1880-1891.
57. Arduíno, D. M.; Esteves, A. R.; Cardoso, S. M.; Oliveira, C. R., Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: Relevance to Parkinson's disease. Neurochem. Int, 2009, 55, (5), 341-348.
58. Rieusset, J., Mitochondria and endoplasmic reticulum: Mitochondria-endoplasmic reticulum interplay in type 2 diabetes pathophysiology. Int. J. Biochem. Cell Biol, 2011, 43(9), 1257-1262.
59. He, Q.; Shi, J.; Jones, S.; An, J.; Liu, Y.; Huang, Y.; Sheikh, M., Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells. Mol. Cell Pharmacol, 2009, 1(1), 23-28.
60. Lautenschlaeger, J.; Prell, T.; Grosskreutz, J., Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler, 2012, 13(2), 166-77.
61. Moenner, M.; Pluquet, O.; Bouchecareilh, M.; Chevet, E., Integrated endoplasmic reticulum stress responses in cancer. Cancer Res, 2007, 67(22), 10631-10634.
62. Bakhshi, J.; Weinstein, L.; Poksay, K.; Nishinaga, B.; Bredesen, D.; Rao, R., Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin. Apoptosis, 2008, 13(7), 904-14.
63. Schröder, M., Endoplasmic reticulum stress responses. Cell Mol. Life Sci. 2008, 65, (6), 862-94.
64. Siegelin, M. D., Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis. Expert. Opin. Ther. Targets, 2012, 16(8), 801-817.
65. Eom, K. S.; Kim, H.-J.; So, H.-S.; Park, R.; Kim, T. Y., Berberine-Induced Apoptosis in Human Glioblastoma T98G Cells Is Mediated by Endoplasmic Reticulum Stress Accompanying Reactive Oxygen Species and Mitochondrial Dysfunction. Biol. Pharm. Bull, 2010, 33(10), 1644-1649.
66. Lee, M.-J.; Kee, K.-H.; Suh, C.-H.; Lim, S.-C.; Oh, S.-H., Capsaicin-induced apoptosis is regulated by endoplasmic reticulum stress-and calpain-mediated mitochondrial cell death pathways. Toxicology, 2009, 264(3), 205-214.
67. Ip, S.-W.; Lan, S.-H.; Huang, A.-C.; Yang, J.-S.; Chen, Y.-Y.; Huang, H.-Y.; Lin, Z.-P.; Hsu, Y.-M.; Yang, M.-D.; Chiu, C.-F.; Chung, J.-G., Capsaicin induces apoptosis in SCC-4 human tongue cancer cells through mitochondria-dependent and-independent pathways. Environ. Toxicol, 2012, 27(6), 332-341.
68. Hour, M.-J.; Huang, L.-J.; Kuo, S.-C.; Xia, Y.; Bastow, K.; Nakanishi, Y.; Hamel, E.; Lee, K.-H., 6-Alkylamino-and 2, 3-Dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization. J. Med. Chem, 2000, 43(23), 4479-4487.
69. Lu, C.-C.; Yang, J.-S.; Chiang, J.-H.; Hour, M.-J.; Lin, K.-L.; Lin, J.-J.; Huang, W.-W.; Tsuzuki, M.; Lee, T.-H.; Chung, J.-G., Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice. PLoS ONE, 2012, 7(5), e36831.
70. Yang, J.-S.; Hour, M.-J.; Huang, W.-W.; Lin, K.-L.; Kuo, S.-C.; Chung, J.-G., MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J. Pharmacol. Exp. Ther, 2010, 334(2), 477-488.
71. Mathupala, S. P.; Ko, Y. H.; Pedersen, P. L., The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim. Biophys. Acta, 2010, 1797, (6-7), 1225-1230.
72. Cao, M.; Li, Q.; Liu, Z.; Liu, H.; Wang, W.; Liao, X.; Pan, Y.; Jiang, J., Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary Pancreat. Dis. Int, 2011, 10(6), 599-604.
73. Siedlakowski, P.; McLachlan-Burgess, A.; Griffin, C.; Tirumalai, S. S.; McNulty, J.; Pandey, S., Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria. Cancer Biol. Ther, 2008, 7(3), 376-384.
74. Cedrón, J.; Del Arco-Aguilar, M.; Estévez-Braun, A.; Ravelo, A., Chemistry and biology of Pancratium alkaloids. Alkaloids Chem. Biol, 2010, 68, 1-37.
75. Rinner, U.; Hudlicky, T., Synthesis of Amaryllidaceae constituents-An update. Synlett, 2005, (3), 365-387.
76. Chiu, W.-H.; Luo, S.-J.; Chen, C.-L.; Cheng, J.-H.; Hsieh, C.-Y.; Wang, C.-Y.; Huang, W.-C.; Su, W.-C.; Lin, C.-F., Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells. Biochem. Pharmacol, 2012, 83(9), 1159-1171.
77. Kim, J. Y.; Lee, S. G.; Chung, J.-Y.; Kim, Y.-J.; Park, J.-E.; Koh, H.; Han, M. S.; Park, Y. C.; Yoo, Y. H.; Kim, J.-M., Ellipticine induces apoptosis in human endometrial cancer cells: The potential involvement of reactive oxygen species and mitogen-activated protein kinases. Toxicology, 2011, 289, (2-3), 91-102.
78. Poljaková, J.; Eckschlager, T.; Hrabeta, J.; Hrebacková, J.; Smutn, S.; Frei, E.; Martínek, V.; Kizek, R.; Stiborová, M., The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells. Biochem. Pharmacol, 2009, 77(9), 1466-1479.
79. Martinkova, E.; Dontenwill, M.; Frei, E.; Stiborova, M., Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells. Neuro. Endocrinol. Lett, 2009, 30(1), 60-6.
80. Stiborová, M.; Poljaková, J.; Martínková, E.; Boek-Dohalská, L.; Eckschlager, T.; Kizek, R.; Frei, E., Ellipticine cytotoxicity to cancer cell lines-a comparative study. Interdiscip. Toxicol, 2011, 4(2), 98-105.
81. Knölker, H.; Reddy, K., Isolation and synthesis of biologically active carbazole alkaloids. Chem. Rev, 2002, 102(11), 4303-427.
82. Schmidt, A.; Reddy, K.; Knölker, H., Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids. Chem. Rev, 2012, 112(6), 3193-328.
83. Fung, S. Y.; Yang, H.; Chen, P., Sequence effect of self-assembling peptides on the complexation and In vitro delivery of the hydrophobic anticancer drug ellipticine. PLoS ONE, 2008, 3(4), e1956.
84. Lu, S.; Wang, H.; Sheng, Y.; Liu, M.; Chen, P., Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition. J. Control Release, 2012, 160(1), 33-40.
85. Wu, M.; Ye, Z.; Liu, Y.; Liu, B.; Zhao, X., Release of hydrophobic anticancer drug from a newly designed self-assembling peptide. Mol. Biosyst, 2011, 7(6), 2040-2047.
86. Gogvadze, V.; Zhivotovsky, B.; Orrenius, S., The Warburg effect and mitochondrial stability in cancer cells. Mol. Aspects Med, 2010, 31(1), 60-74.
87. Li, L.; Ishdorj, G.; Gibson, S. B., Reactive oxygen species regulation of autophagy in cancer: Implications for cancer treatment. Free Radic. Biol. Med, 2012, 53(7), 1399-1410.
88. Notte, A.; Leclere, L.; Michiels, C., Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol, 2011, 82(5), 427-434.
89. Azad, M.; Chen, Y.; Gibson, S., Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid. Redox Signal, 2009, 11(4), 777-790.
90. Gong, K.; Chen, C.; Zhan, Y.; Chen, Y.; Huang, Z.; Li, W., Autophagy-related gene 7 (Atg7) and reactive oxygen species (ROS)/extracellular-signal-regulated kinase (ERK) regulate tetrandrineinduced autophagy in human hepatocellular carcinoma. J. Biol. Chem, 2012, 287(42), 35576-35588.
91. Liu, C.; Gong, K.; Mao, X.; Li, W., Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int. J. Cancer, 2011, 129(6), 1519-1531.
92. Ma, D.; Tremblay, P.; Mahngar, K.; Akbari-Asl, P.; Collins, J.; Hudlicky, T.; McNulty, J.; Pandey, S., A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen. Invest. New Drugs, 2012, 30(3), 1012-1027.
93. Ma, D.; Tremblay, P.; Mahngar, K.; Collins, J.; Hudlicky, T.; Pandey, S., Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin. PLoS ONE, 2011, 6(12), e28780.
94. Griffin, C.; McNulty, J.; Pandey, S., Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells. Int. J. Oncol, 2011, 38(6), 1549-1556.
95. Karna, P.; Zughaier, S.; Pannu, V.; Simmons, R.; Narayan, S.; Aneja, R., Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent. J. Biol. Chem, 2010, 285(24), 18737-18748.
96. Boya, P.; González-Polo, R.-A.; Casares, N.; Perfettini, J.-L.; Dessen, P.; Larochette, N.; Métivier, D.; Meley, D.; Souquere, S.; Yoshimori, T.; Pierron, G.; Codogno, P.; Kroemer, G., Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol, 2005, 25(3), 1025-1040.
97. Semenza, G. L., Mitochondrial autophagy: Life and breath of the cell. Autophagy, 2008, 4(4), 534-536.
98. Zhang, H.; Bosch-Marce, M.; Shimoda, L. A.; Tan, Y. S.; Baek, J. H.; Wesley, J. B.; Gonzalez, F. J.; Semenza, G. L., Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem, 2008, 283 (16), 10892-10903.
99. Rouschop, K. M. A.; Ramaekers, C. H. M. A.; Schaaf, M. B. E.; Keulers, T. G. H.; Savelkouls, K. G. M.; Lambin, P.; Koritzinsky, M.; Wouters, B. G., Autophagy is required during cycling hypoxia to lower production of reactive oxygen species. Radiother. Oncol, 2009, 92(3), 411-416.
100. Bayet-Robert, M.; Lim, S.; Barthomeuf, C.; Morvan, D., Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Biochem. Pharmacol, 2010, 80(8), 1170-1179.
101. Dirsch, V. M.; Kirschke, S. O.; Estermeier, M.; Steffan, B.; Vollmar, A. M., Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria. Oncogene, 2003, 23(8), 1586-1593.
102. Scarpulla, R., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev, 2008, 88, 611-638.
103. Samper, E.; Morgado, L.; Estrada, J.; Bernad, A.; Hubbard, A.; Cadenas, S.; Melov, S., Increase in mitochondrial biogenesis, oxidative stress, and glycolysis in murine lymphomas. Free Radic. Biol. Med, 2009, 46(3), 387-96.
104. Wang, X.; Moraes, C., Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Mol. Oncol, 2011, 5(5), 399-409.
105. Voccoli, V.; Colombaioni, L., Mitochondrial remodeling in differentiating neuroblasts. Brain Res, 2009, 1252, 15-29.
106. Evtodienko, Y. V.; Teplova, V. V.; Sidash, S. S.; Ichas, F.; Mazat, J.-P., Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria. FEBS Letters. 1996, 393, (1), 86-88.
107. Brown, K. C.; Witte, T. R.; Hardman, W. E.; Luo, H.; Chen, Y. C.; Carpenter, A. B.; Lau, J. K.; Dasgupta, P., Capsaicin displays antiproliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS ONE, 2010, 5(4), e10243.
108. Kim, M. Y.; Trudel, L. J.; Wogan, G. N., Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res, 2009, 29(10), 3733-3740.
109. Mori, A.; Lehmann, S.; O'Kelly, J.; Kumagai, T.; Desmond, J. C.; Pervan, M.; McBride, W. H.; Kizaki, M.; Koeffler, H. P., Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res, 2006, 66(6), 3222-3229.
110. Thoennissen, N. H.; O'Kelly, J.; Lu, D.; Iwanski, G. B.; La, D. T.; Abbassi, S.; Leiter, A.; Karlan, B.; Mehta, R.; Koeffler, H. P., Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and-negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene, 2009, 29(2), 285-296.
111. Le, T.-D.; Jin, D. C.; Rho, S. R.; Kim, M. S.; Yu, R.; Yoo, H., Capsaicin-induced apoptosis of FaDu human pharyngeal squamous carcinoma cells. Yonsei Med. J, 2012, 53(4), 834-841.
112. Artal-Sanz, M.; Tavernarakis, N., Prohibitin and mitochondrial biology. Trends Endocrinol. Metab, 2009, 20(8), 394-401.
113. Osman, C.; Merkwirth, C.; Langer, T., Prohibitins and the functional compartmentalization of mitochondrial membranes. J. Cell Sci, 2009, 122 (21), 3823-3830.
114. Merkwirth, C.; Langer, T., Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta, 2009, 1793(1), 27-32.
115. Cerquaglia, C.; Diaco, M.; Nucera, G.; La Regina, M.; Montalto, M.; Manna, R., Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr. Drug Targets Inflamm. Allergy, 2005, 4(1), 117-124.
116. Cocco, G.; Chu, D. C. C.; Pandolfi, S., Colchicine in clinical medicine. A guide for internists. Eur. J. Intern. Med, 2010, 21(6), 503-508.
117. Chen, X.-m.; Liu, J.; Wang, T.; Shang, J., Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways. Toxicol. In vitro, 2012, 26(5), 649-655.
118. De Vincenzo, R.; Ferlini, C.; Distefano, M.; Gaggini, C.; Riva, A.; Bombardelli, E.; Morazzoni, P.; Valenti, P.; Belluti, F.; Ranelletti, F.; Mancuso, S.; Scambia, G., In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother. Pharmacol, 2000, 46(4), 305-312.
119. De Vincenzo, R.; Scambia, G.; Ferlini, C.; Distefano, M.; Filippini, P.; Riva, A.; Bombardelli, E.; Pocar, D.; Gelmi, M.; Benedetti, P. P.; Mancuso, S., Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines. Anticancer Drug Des, 1998, 13(1), 19-33.
120. Niel, E.; Scherrmann, J., Colchicine today. Joint Bone Spine, 2006, 73(6), 672-8.
121. Ben-Chetrit, E.; Levy, M., Colchicine: 1998 update. Semin. Arthritis Rheum, 1998, 28(1), 48-59.
122. Karbowski, M.; Spodnik, J.; Teranishi, M.; Wozniak, M.; Nishizawa, Y.; Usukura, J.; Wakabayashi, T., Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells. J. Cell Sci, 2001, 114(2), 281-91.
123. Berridge, M.; Tan, A., Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessig the Warburg effect. Rejuvenation Res, 2010, 13(2-3), 139-141.
124. Isidoro, A.; Martínez, M.; Fernández, P.; Ortega, A.; Santamaría, G.; Chamorro, M.; Reed, J.; Cuezva, J., Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J, 2004, 378(1), 17-20.
125. Xiong, S.; Pang, H.-d.; Fan, J.; Ge, F.; Yang, X.-x.; Liu, Q.-y.; Liao, X.-j.; Xu, S.-h., In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action. Bri. J. Pharmacol. 2010, 159(4), 909-918.
126. Zhang, Z.-f.; Guo, Y.; Zhang, J.-b.; Wei, X.-h., Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 Cell. Arch. Pharm. Res, 2011, 34(5), 791-800.
127. Yang, Z.-G.; Chen, A. Q.; Liu, B., Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chem. Biodivers, 2009, 6(6), 924-933.
128. Kobayashi, J.; Morita, H., The Lycopodium alkaloids. Alkaloids Chem. Biol, 2005, 61, 1-57.
129. Mandal, S. K.; Biswas, R.; Bhattacharyya, S. S.; Paul, S.; Dutta, S.; Pathak, S.; Khuda-Bukhsh, A. R., Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur. J. Pharmacol, 2010, 626(2-3), 115-122.
130. Jin, Z., Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep, 2009, 26(3), 363-81.
131. Lamoral-Theys, D.; Decaestecker, C.; Mathieu, V.; Dubois, J.; Kornienko, A.; Kiss, R.; Evidente, A.; Pottier, L., Lycorine and its derivatives for anticancer drug design. Mini Rev. Med. Chem, 2010, 10(1), 41-50.
132. McNulty, J.; Nair, J.; Bastida, J.; Pandey, S.; Griffin, C., Structureactivity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells. Phytochemistry, 2009, 70(7), 913-9.
133. Liu, X.; Jiang, J.; Jiao, X.; Wu, Y.; Lin, J.; Cai, Y., Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. Cancer Lett, 2009, 274(1), 16-24.
134. Han, Y.; Zhang, S.; Wu, J.; Yu, K.; Zhang, Y.; Yin, L.; Bi, L., Matrine induces apoptosis of human multiple myeloma cells via activation of the mitochondrial pathway. Leuk. Lymphoma, 2010, 51(7), 1337-1346.
135. Carmely, S.; Ilan, M.; Kashman, Y., 2-amino imidazole alkaloids from the marine sponge Leucetta chagosensis. Tetrahedron, 1989, 45, 2193-2200.
136. LaBarbera, D.; Modzelewska, K.; Glazar, A.; Gray, P.; Kaur, M.; Liu, T.; Grossman, D.; Harper, M.; Kuwada, S.; Moghal, N.; Ireland, C., The marine alkaloid naamidine A promotes caspasedependent apoptosis in tumor cells. Anticancer Drugs, 2009, 20(6), 425-436.
137. Liu, M.; Luo, X.; Liao, F.; Lei, X.; Dong, W., Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol, 2011, 67(3), 605-612.
138. Aneja, R.; Miyagi, T.; Karna, P.; Ezell, T.; Shukla, D.; Vij Gupta, M.; Yates, C.; Chinni, S. R.; Zhau, H.; Chung, L. W. K.; Joshi, H. C., A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells. Eur. J. Cancer, 2010, 46(9), 1668-1678.
139. McLachlan, A.; Kekre, N.; McNulty, J.; Pandey, S., Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis, 2005, 10(3), 619-630.
140. Park, C.; Shin, H. J.; Kim, G.-Y.; Kwon, T. K.; Nam, T.-J.; Kim, S.-K.; Cheong, J.; Choi, I.-W.; Choi, Y. H., Induction of apoptosis by streptochlorin isolated from Streptomyces sp. in human leukemic U937 cells. Toxicol. in vitro, 2008, 22, (6), 1573-1581.
141. Li, Z.; Xu, X.; Huang, Y.; Ding, L.; Wang, Z.; Yu, G.; Xu, D.; Li, W.; Tong, D., Swainsonine activates mitochondria-mediated apoptotic pathway in human lung cancer A549 cells and retards the growth of lung cancer xenografts. Int. J. Biol. Sci, 2012, 8(3), 394-405.
142. Huang, S.-M.; Hsu, P.-C.; Chen, M.-Y.; Li, W.-S.; More, S. V.; Lu, K.-T.; Wang, Y.-C., The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. Int. J. Cancer, 2012, 131(3), 722-732.